WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) will unveil innovative enhancements to its Quell ® Wearable Pain Relief Technology™ at the 2016 CES Event January 6-9 in Las Vegas . CES is the largest consumer technology event and has served as the launch pad for innovators and

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will unveil Quell™, the Company's wearable pain relief device at the International Consumer Electronics Show (CES) in Las Vegas in January 2015 . Quell™ Wearable Pain Relief Device (Photo: Business Wire)

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that the Company's Quell ® Wearable Pain Relief Technology™ has won the Electronics Retailer Association Moxie Award for the Best Health Show 2016. This Moxie award recognizes the year's best direct response

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO) announced that it was the recipient of the Smaller Businesses Association of New England (SBANE) New England Innovation Award for the development and successful launch of Quell ® Wearable Pain Relief Technology™.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that Quell ®  Wearable Pain Relief Technology™ will be featured for the second year in a row at the American Society for Regional Anesthesia's Annual Pain Medicine Meeting to be held November 17-19 in San

100% Drug Free, FDA Cleared Wearable for Widespread Relief from Chronic Pain WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured for the second year in a row at the American Podiatric Medical

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that it was granted the American Podiatric Medical Association (APMA) Seal of Approval for its Quell Wearable Pain Relief device. "The APMA Seal of Approval is awarded after a rigorous scientific review by a group of APMA

WOBURN, Mass. , Jan. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today announced the shift of its 2019 financial conference call to Monday, January 27, 2020 at 8:00am Eastern Time . Internal scheduling conflicts caused the delay of two business days.

NeuroMetrix, Inc. Announces Conference Call to Discuss American Diabetes Association 72nd Scientific Sessions and Other Business Activities WALTHAM, Mass. --(BUSINESS WIRE)--Jun. 18, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , today said it will host a conference call at 10:00

NeuroMetrix, Inc. Announces Date for 2010 Fourth Quarter Financial Results Conference Call WALTHAM, Mass., Jan 26, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2010 fourth quarter financial results before the opening of the market on February 3, 2011.